Recombinant clotting factors

Recombinant clotting factors are man-made proteins used to help people with bleeding disorders, such as hemophilia, where the body lacks certain proteins needed for blood clotting. These factors are created using genetic engineering techniques, where scientists insert the DNA for the clotting proteins into cells, allowing these cells to produce large amounts of the proteins. Unlike traditional treatments derived from human blood, recombinant factors are produced in a controlled environment, reducing the risk of infections. They are administered to patients to prevent or treat bleeding episodes, improving their quality of life and enabling more normal activities.